|
|
|
Volumn 18, Issue 14 Suppl 13, 2004, Pages 15-22
|
|
Antifungal resistance: the clinical front.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B;
ANTIFUNGAL AGENT;
CASPOFUNGIN;
CYCLOPEPTIDE;
FLUCONAZOLE;
PYRIMIDINE DERIVATIVE;
THIAZOLE DERIVATIVE;
TRIAZOLE DERIVATIVE;
VORICONAZOLE;
ANTIBIOTIC RESISTANCE;
CANDIDA;
CANDIDIASIS;
DISEASE TRANSMISSION;
DRUG EFFECT;
HEALTH STATUS;
HUMAN;
REVIEW;
RISK FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
AMPHOTERICIN B;
ANTIBIOTICS, ANTIFUNGAL;
ANTIFUNGAL AGENTS;
CANDIDA;
CANDIDIASIS;
DRUG RESISTANCE, FUNGAL;
FLUCONAZOLE;
HEALTH STATUS;
HUMANS;
PEPTIDES, CYCLIC;
PYRIMIDINES;
RISK FACTORS;
THIAZOLES;
TREATMENT OUTCOME;
TRIAZOLES;
UNITED STATES;
|
|
EID: 17244364065
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (22)
|
|
References (48)
|
